Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease
Prenatal Diagnosis · 2025-09 · 45 (10) · 1325-1333
DOI: 10.1002/pd.6650 ↗At a glance
Journal article in Prenatal Diagnosis, published online on 2024-08-30. Written by Chrystalle Katte Carreon and 5 co-authors. Institution: Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA. Major MEDLINE topics: Heart Defects, Congenital, Placenta, Umbilical Cord, Placenta Diseases. Cited 9 times so far (Crossref); 48 references. Funded by: NICHD NIH HHS, American Heart Association Career Development, NIH HHS.
Abstract (original language)
Objective
Impairments in the maternal‐fetal environment are associated with adverse postnatal outcomes among infants with congenital heart disease. Therefore, we sought to investigate placental anomalies as they related to various forms of fetal congenital heart disease (FCHD).
Methods
We reviewed the placental pathology in singleton pregnancies with and without FCHD. FCHD was divided into separate categories (transposition physiology, obstructive left, obstructive right, biventricular without obstruction, and others). Exclusion criteria included other prenatally known structural malformations and/or aneuploidy. The significance threshold was set at p < 0.05 or False Discovery rate q < 0.05 when multiple tests were performed.
Results
The cohort included 215 FCHD and 122 non‐FCHD placentas. FCHD placentas showed increased rates of maternal vascular malperfusion (24% vs. 5%, q < 0.001) and cord anomalies (27% vs. 1%, q < 0.001). Placentas with fetal TGA demonstrated a lower rate of hypoplasia when compared with other FCHD types (1/39 vs. 51/176, Fisher's exact p = 0.015).
Conclusion
Placental maternal vascular malperfusion is increased in FCHD. The prevalence of vascular malperfusion did not differ by FCHD type, indicating that CHD type does not predict the likelihood of placental vascular dysfunction. Further investigation of the placental‐fetal heart axis in FCHD is warranted given the importance of placental health.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pediatric Cardiology and Pediatric Intensive Care, Ludwig Maximilian University, Munich, Germany.
ORCID profiles: Christina Ronai, Sarah U Morton
Funding
- NICHD NIH HHS
- American Heart Association Career Development
- NIH HHS
- American Heart Association
- National Institutes of Health
Cite
APA
Carreon, C. K., Ronai, C., Hoffmann, J. K., Tworetzky, W., Morton, S. U., & Wilkins-Haug, L. E. (2025). Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease. Prenatal Diagnosis, 45(10), 1325-1333. https://doi.org/10.1002/pd.6650
Vancouver
Carreon CK, Ronai C, Hoffmann JK, Tworetzky W, Morton SU, Wilkins-Haug LE. Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease. Prenatal Diagnosis. 2025;45(10):1325-1333. doi:10.1002/pd.6650
BibTeX
@article{Carreon2025,
author = {Carreon, Chrystalle Katte and Ronai, Christina and Hoffmann, Julia K and Tworetzky, Wayne and Morton, Sarah U and Wilkins-Haug, Louise E},
title = {Maternal Vascular Malperfusion and Anatomic Cord Abnormalities Are Prevalent in Pregnancies With Fetal Congenital Heart Disease},
journal = {Prenatal Diagnosis},
year = {2025},
volume = {45},
number = {10},
pages = {1325--1333},
doi = {10.1002/pd.6650}
}
EUVIMED